AI Innovation for automated Detection and Classification of osteoporotic Fractures of the Spine in CT Scans - ImageBiopsy Lab launches IB Lab FLAMINGO

2023-11-29

放射疗法

Currently more than two-thirds of spinal fractures stay undiagnosed. IB Lab FLAMINGO analyzes any CT images of the upper extremities (thorax, abdomen) that include the spine. Therefore, no additional examinations, radiation exposure or costs are required. Developed by UCB, a global biopharmaceutical company, IB Lab FLAMINGO is integrated into ImageBiopsy Lab's ZOO MSK platform, targeting hospitals to reduce overlooked spinal fractures and support early diagnosis and treatment of osteoporosis. VIENNA, Nov. 29, 2023 /PRNewswire/ -- ImageBiopsy Lab, a pioneer in medical imaging, introduces IB Lab FLAMINGO at this year's RSNA conference. The fully automated software identifies asymptomatic spinal fractures in CT scans. Utilizing the gold standard Genant classification, IB Lab FLAMINGO highlights relevant fractures and empowers proactive treatment for healthcare professionals. "Our partnership with UCB highlights the potential of leveraging AI for improving care for many diseases, including osteoporosis" explains Richard Ljuhar, CEO at ImageBiopsy Lab. Understanding the Osteoporosis Challenge "Together with expert clinicians, UCB developed this deep-learning computational model that can detect vertebral compression fractures on CT scans. ImageBiopsy Lab as a musculoskeletal (MSK) radiology AI company has refined the technology and is now ready to integrate it into clinical care. Given that 80% of fragility fractures today remain undiagnosed and untreated, we're excited about the potential of IB Lab FLAMINGO to help close the global treatment gap in osteoporosis", said Jen Timoshanko, Head of Medical Affairs, Bone Health Mission at UCB. Osteoporosis impacts around 200 million globally, leading to 9 million fragility fractures annually, most of them vertebral (VFs). Its silent progression can cause pain, reduced mobility, and diminished quality of life. Apart from personal suffering, fragility fractures strain global public health systems, escalating treatment costs and mortality rates, posing societal challenges. "In an ageing society, osteoporosis and its consequences, especially geriatric fractures, challenge patients, physicians, and healthcare systems. IB Lab FLAMINGO's ability to detect vertebral fractures offers a crucial, automated solution for early risk assessment and targeted treatment in addressing osteoporosis complexities." Prof. Andreas Kurth, Director of the Center for Orthopaedics and Trauma Surgery at Marienhaus Klinikum Mainz, Germany, expressed the need for a meaningful solution. Annalisa Blaha marketing@imagebiopsy.com +43 1905 12061104 About ImageBiopsy Lab Vienna-based ImageBiopsy Lab is at the forefront of medical imaging technology, developing innovative AI solutions to improve patient outcomes. -> Follow us on LinkedIn About UCB UCB, is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB is listed on Euronext Brussels (symbol: UCB). -> Follow us on Twitter: @UCB_news. Note: The information provided in this press release is accurate as of the date of publication and is subject to change without notice. Photo - Logo - View original content to download multimedia: SOURCE ImageBiopsy Lab

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构